The MedTech Step-Up Webinar
The MedTech Step-Up Webinar
Podcast Description
Welcome to Lifeblood’s MedTech Step-Up Webinar where our aim is to make you venture backable. At Lifeblood, we understand that transforming a groundbreaking medical innovation into a venture-backable company requires more than just a great idea—it demands the right strategic approach, team, and industry insight . Lifeblood Our Step-Up Program is designed to bridge the gap between innovation and investment readiness. We provide early-stage MedTech companies with a comprehensive, founder-first roadmap, addressing critical legal, business and financial advisory, team building, and marketing strategies. Lifeblood Through tactical, step-by-step guidance, we aim to equip you with the tools and insights necessary to attract serious capital and achieve long-term growth. Lifeblood We’re excited to embark on this journey with you, turning your MedTech innovation into a thriving, industry-changing reality. This is the MedTech Step-Up Program.
Podcast Insights
Content Themes
Focuses on the critical elements required for making MedTech innovations venture-backable, with episodes discussing investment readiness, strategic team building, and market entry strategies. Examples include discussions on fundraising challenges in 'Why You Aren't Raising Capital' and insights on industry trends in 'Investment & Economic Outlook'.
Welcome to Lifeblood’s MedTech Step-Up Webinar where our aim is to make you venture backable.
At Lifeblood, we understand that transforming a groundbreaking medical innovation into a venture-backable company requires more than just a great idea—it demands the right strategic approach, team, and industry insight . Lifeblood
Our Step-Up Program is designed to bridge the gap between innovation and investment readiness. We provide early-stage MedTech companies with a comprehensive, founder-first roadmap, addressing critical legal, business and financial advisory, team building, and marketing strategies. Lifeblood
Through tactical, step-by-step guidance, we aim to equip you with the tools and insights necessary to attract serious capital and achieve long-term growth. Lifeblood
We’re excited to embark on this journey with you, turning your MedTech innovation into a thriving, industry-changing reality.
This is the MedTech Step-Up Program.
Hosts:
Joseph Snyder
Head of Talent and Co-Founder, Lifeblood
https://www.linkedin.com/in/josephasnyder1/
Cristiano Fontana
Head of Advisory, Lifeblood
https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/
Guests:
Tim Jones
CEO, Symphysis Medical
Tim Jones is the CEO of SymPhysis Medical, an Irish MedTech start-up developing innovative solutions for the management of pleural effusions. Prior to founding SymPhysis Medical, Tim held key roles at Medtronic, where he gained hands-on experience in global MedTech operations, product development, and market access strategies within one of the world’s leading medical technology companies. At SymPhysis, Tim has led the company from early-stage concept through clinical validation, securing private investment and highly competitive non-dilutive funding, while earning international recognition for advancing patient-centric design in MedTech innovation.
https://www.linkedin.com/in/tim-jones-1a004040/
Daniel O-Mahony
Partner, Seroba
Daniel O’Mahony is a Partner at Seroba, where he leverages over two decades of experience in life sciences, spanning product development, strategic planning, licensing, corporate venturing, and intellectual property commercialisation. He began his investment career in corporate venture at Elan Corporation and later became a partner at Kernel Capital, before joining Seroba in 2009.
With a strong foundation in both academia and technology transfer, Daniel previously held research and teaching roles at Trinity College Dublin, the Geisinger Clinic in Pennsylvania, and University College Dublin. He also led the Technology Transfer Office at the University of Galway, where he secured several high-value licensing agreements.
https://www.linkedin.com/in/daniel-o-mahony-b02a1413/
Joey Mason
Venture Partner, Claret Capital Partners
Joey Mason has spent 30 years working in life sciences as an investor, entrepreneur, financier, director, mentor and advisor. He is currently a Venture Partner at Claret Capital Partners, a London-based venture debt firms. Joey also serves as a Venture Advisor to Sofinnova Partners, one of Europe’s leading healthcare investment firm.
Joey has significant experience in most segments of the industry – medtech, pharma/ biotech, diagnostics, health IT and techbio. He has served on the boards of 20 private and public companies in Ireland, Europe and the USA and also on the board of EVCA (InvestEurope), the trade association for the private equity industry in Europe. In 2021, he co-founded Duplex Capital Partners to advise companies innovating in the digitalisation of life sciences. Prior to this he led a Life Science fund at M Ventures, Merck KGaA’s corporate venture arm, from 2018 – 2020 in Amsterdam, having spent 10 years at Delta Partners from 2004, where he was responsible for its most profitably exited investment.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.